Nikhil Prasad Fact checked by:Thailand Medical News Team Jul 02, 2024 4 months, 2 weeks, 6 days, 23 hours, 31 minutes ago
Cancer News: Cancer continues to be one of the leading causes of death worldwide, posing a significant challenge to global healthcare systems. Despite advancements in cancer treatments, high mortality rates and the development of treatment-resistant tumors necessitate the discovery of new therapeutic options. Researchers are now exploring compounds with dual properties - anticancer and antioxidant activities - to address this need. One such promising discovery covered in this
Cancer News report involves the discovery of derivatives of 3-((4-hydroxyphenyl)amino)propanoic acid by researchers from Lithuania and potential anticancer and antioxidant therapeutic agents.
.jpg)
Promising Antioxidant Anticancer Compounds
Image - AI Generated
The Quest for Dual-Purpose Compounds
Reactive oxygen species (ROS) are known to play a crucial role in the development and progression of cancer. ROS can cause oxidative stress, leading to damage in cellular components, which contributes to cancer pathogenesis. Moreover, ROS are involved in the response of cancer cells to chemotherapeutic agents. Therefore, developing compounds that can both combat cancer and mitigate oxidative stress is a promising strategy.
In a recent study, the study team from Lithuania evaluated a series of 3-((4-hydroxyphenyl)amino)propanoic acid derivatives (compounds 1-36) for their anticancer and antioxidant activities. This study aimed to identify candidates that could be developed into effective anticancer drugs with additional antioxidant benefits.
Key Findings: Effective Against Cancer Cells
The study revealed that certain compounds among the 3-((4-hydroxyphenyl)amino)propanoic acid derivatives demonstrated significant anticancer activity. Compounds 12, 20-22, and 29 were particularly noteworthy, as they were able to reduce the viability of A549 lung cancer cells by 50%.
Additionally, these compounds showed a remarkable ability to suppress the migration of A549 cells, a key factor in preventing cancer metastasis.
Antioxidant Potential
Among the tested compounds, compound 20 stood out for its potent antioxidant properties. It exhibited strong activity in the DPPH radical scavenging assay, which measures the ability of a compound to neutralize free radicals. This antioxidant capability is particularly important as it helps in reducing oxidative stress, thereby potentially preventing cancer progression and improving the effectiveness of anticancer treatments.
Safety Profile
A major concern in developing new anticancer drugs is their potential toxicity to noncancerous cells. The study found that the promising compounds also displayed favorable cytotoxicity profiles towards noncancerous Vero cells. This suggests that these compounds could offer a safer alternative to existing chemotherapeutic agents, which often have severe side effects.
&l
t;br />
Mechanism of Action
The anticancer and antioxidant activities of these compounds are believed to be linked to their chemical structure. The presence of the 4-hydroxyphenyl group is thought to play a critical role in their effectiveness. This group is known to interact with various cellular targets involved in cancer progression and oxidative stress response. The exact mechanisms are still under investigation, but the initial findings are promising.
Next Steps: From Lab to Clinic
The identification of these compounds as potential anticancer and antioxidant agents is just the beginning. Further research is needed to fully understand their mechanisms of action and to optimize their chemical structures for maximum effectiveness. Preclinical studies, including animal models, will be essential to evaluate the safety and efficacy of these compounds in vivo.
If successful, these compounds could proceed to clinical trials, where they would be tested in humans. The journey from lab to clinic is long and complex, but the potential benefits of these compounds make the effort worthwhile.
Conclusion
The discovery of 3-((4-hydroxyphenyl)amino)propanoic acid derivatives with both anticancer and antioxidant properties offers new hope in the fight against cancer. These compounds not only target cancer cells but also help in reducing oxidative stress, which is a major contributor to cancer progression and resistance to treatment. While more research is needed, the initial findings are promising and could lead to the development of safer and more effective cancer therapies.
Final Thoughts
Cancer remains a formidable challenge, but advances in research continue to bring us closer to finding effective treatments. The dual-action compounds discussed in this study represent a significant step forward, offering the possibility of treating cancer more effectively while minimizing side effects. As research progresses, we can hope for new therapies that will improve the lives of those affected by this devastating disease.
The study findings were published in the peer reviewed journal: Molecules.
https://www.mdpi.com/1420-3049/29/13/3125
For the latest
Cancer News, keep on logging to Thailand Medical News.
Read Also:
https://www.thailandmedical.news/news/unlocking-the-secrets-of-tumor-dormancy-and-reactivation
https://www.thailandmedical.news/news/the-hidden-role-of-metals-in-cancer-a-double-edged-sword
